Close

Jump to:

  • Navigation
  • Content
  • Footer
DAME hero image

DAME

Follow

High-performance sustainable period products that are better for your body and the planet.

155%
 - 
Funded 7 Dec 2022
£650,001 target
£1,020,098 from 746 investors
More
Less

Business overview

Location London, United Kingdom
Social media
Website wearedame.co
Sectors Healthcare Non-Digital Mixed B2B/B2C
Company number 08509842
Incorporation date 30 Apr 2013
More
Less

Investment summary

Type Equity
Valuation (pre-money) £7.5M
Equity offered 11.89%
Share price £0.0411
Tax relief

EIS

More
Less

Business highlights

  • Listings in Boots, Waitrose, Sainsbury's, Planet Organic & ASOS
  • B Corp since 2019 and 1st Carbon Neutral Plus accredited business
  • Sales in over 60 countries to 48k customers
  • Multi award-winning with world-first patented products
More
Less

Key features

  • Secondary Market
  • Nominee investment min. £12.33 +
  • Direct investment min. £25,000.00 +
  • Idea
  • Key Information
  • Investor Rewards
  • Team
  • Updates
  • Investors 746
  • Discussion
  • Documents

Idea

Introduction

DAME designs, manufactures, and sells organic and reusable period products. We were founded by Celia Pool and Alec Mills to tackle the billions of plastic period products thrown away globally each year and decades of big period brands selling discretion and shame.

So in 2018 we launched the world's first Reusable Tampon Applicator on Kickstarter and our own range of toxin-free organic cotton tampons. It sold in over 60 countries, picked up multiple global awards, and now in retailers nationwide. To date, we estimate it's saved over 20 million plastic disposables from going to landfill.

We’ve continued innovating, and have since expanded our range to include Reusable Pads with patent pending DAMEdry™ technology, and are soon to launch Period Pants with a waitlist of over 6,000 people. As a B Corp and the first Carbon Neutral Plus company to be recognised by Carbonfootprint, impact is at our core - attracting collaboration offers from the likes of Finisterre and others.

Our vision is to create a world where periods hold no body back, improving the lives of billions of people around the world.

Substantial accomplishments to date

• Over £2.1m revenue* and 100,000 units sold since trading began in 2019
We aim for this to grow substantially as we launch more NPD.

• Almost 100% YoY revenue growth via D2C and nationwide retail listings between Dec 21 and Dec 20
We’ve historically enjoyed incredible growth by benefitting from virality thanks to our unique and innovative products.

• Patented technology and IP in multiple territories
Our applicator is a world first-to-market innovation and our unique DAMEdry™ construction used in our reusable pads is patent pending in both the EU and UK.

• We estimate around 20 million+ plastic period products saved from landfills
With this figure growing daily.

• Multi award-winning products and company
Accolades include:
⁃ Fast Company, World Changing Ideas 2019
⁃ Escape the City, Top 100 2019
⁃ Dezeen Award 2019
⁃ Business Green, Leaders Award 2019
⁃ Sunday Times Style, Beauty Awards Finalist 2022
⁃ Indy Best Buy 2022
⁃ Veuve Clicquot, Bold Woman 2021

• Backed by Innovate UK and Sky Ocean Ventures
Which has now moved to Founders Factory, where we benefit from ongoing growth support.

• Over 10M views on TikTok
We regularly go ‘viral’ on TikTok and have growing social channels with over 100 influencers who have posted about us. Our mailing list is over 100k meaning a huge audience for new product launches.

• Thousands reached with TV and bus campaigns
We ran the first ad to feature a tampon string on 200 London buses. Our first TV ad reached thousands of households and resulted in incredible brand recall and uplift.

• Collaborations with Finisterre and marketing giveaways with Wild, UpCircle, Tony’s Chocolonely and Too Good To Go, Little Moons and more...

Like-minded businesses love collaborating with us both physically and online.

*Based on unaudited management accounts

Monetisation strategy

We achieved market validation on Kickstarter by overfunding to nearly 300%, before being picked up by major UK supermarkets. We're currently stocked in Sainsbury's, Boots, Waitrose, Planet Organic, and ASOS, feeding into our omnichannel strategy.

Two thirds of our revenue comes from online sales. Here we benefit from a 65% average product margin, valuable data insights, and monthly subscription revenue.

New higher value products have increased basket sizes and our customer lifetime value has risen from from £29 to £58 for our September 2019 cohort.

Our customers are asking us for more products that answer the global need for a better and more sustainable health and beauty care. This will take us beyond periods with the aim to become a £100m+ household brand.

We recently won ≈ £200k from the John Lewis Circular Grant to find a solution to increase menstrual cup adoption and continued use.

Use of proceeds

The last 6 months we have focussed on increasing our contribution margin*, reaching break-even on first purchase for 3 consecutive months.

*Based on an average product margin of 60%.

The next twelve months focus will be on scaling our sustainable growth, aiming to be profitable by YE 2023.

•40% Brand & Marketing

This year we've reduced CAC by 50%. Now we plan to scale these mechanics, building on content-lead organic traffic, strategic collaborations, meaningful and explosive campaigns, and driving trial of our products.

•30% Team

We have an experienced and passionate core team and we're now in the process of hiring a new Head of Ops.

•15% Product Launches

This year we’re testing our everyDAME™ range, offering period pants in a variety of sizes and styles at an accessible price point, to drive market penetration. We have a strong pipeline of launches throughout the year.

•15% E-commerce

We're upgrading our software (e.g. ReCharge & Shopify) and improving our tech to increase basket size and upsells, customer lifetime value; and further improve our strong 5% conversion rate on website visits.

Key Information

Debt

The company currently has a bridging loan in place of £300K with Alternative Bridging Association at an interest rate of 3%. This was taken out in September 2021 with a period of 24 months.

The intention of the business is to refinance this loan into a Director's loan with indicative terms below:

1. Principle repayment of £3k per month
2. Balloon payment of interest of 10% pa will be paid with the final repayment
3. Option to convert the outstanding principle at 20% discount to the next fundraise, with the share price in this round being the minimum price of this conversion (5p per share).
4. Secured over Intellectual Property and Stock

Funds from this round will not be used to repay this loan.

Share Class

The company currently has two classes of shares, A Ordinary Shares and Ordinary Shares. Investors in this round will be receiving A Ordinary shares.

The rights attached to the share classes are as follows:

A Ordinary Shares:
•Voting rights
•1x non-participating preference on liquidation and exit: A Ordinary Shareholders will first receive their initial investment amount before the remaining proceeds are distributed between all shareholders pro rata.

Ordinary Shares:
•Voting rights
•No exit or liquidation preference.

Investor Rewards

Please note that any discounts, rewards and/or offers listed by a company in its campaign are subject to the terms and conditions applied by that company. It is the company’s responsibility to honour such discounts, rewards and/or offers and Seedrs does not take any responsibility for them.

Open an account to get access to the team members of DAME

Sign up

Already have an account? Log in

To comply with financial regulations, we can only show full campaign details to registered users.

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Share on:

Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future.

This campaign for DAME has been approved by Seedrs Limited (trading as Republic Europe) ("Republic Europe", "us" or "we"), as of 25 October 2022 as a financial promotion. Republic Europe is authorised and regulated by the Financial Conduct Authority with firm reference number 550317. In approving this campaign, Republic Europe has concluded that the information, taken as a whole, is "fair, clear and not misleading." This means that for factual statements we have reviewed evidence of their accuracy, and that for aspirational statements we believe they are phrased appropriately in light of their speculative nature. You should note that in the case of factual statements, the evidence we review is provided by the business, and we do not audit it, which means that we may not be able to identify forged or altered evidence. You should further note that in the case of aspirational statements, the nature of the type of businesses presented on the Republic Europe platform is such that they are likely to have high ambitions, and we may approve statements that convey those ambitions even where we do not believe, or we do not have a view on whether it is likely, that they will be fully realised. The pre-money valuation and investment sought in the campaign are those set by the business: they are not reviewed or established by us, and the valuation is not an independent view of what the business is worth. Given the nature and type of businesses presented on the Republic Europe platform, it is possible that the business has very little cash remaining prior to receiving this investment, and the investment sought may be necessary for the business's on-going existence.

Republic Europe does not make investment recommendations to you. No communications from Republic Europe, through this website or any other medium, should be construed as an investment recommendation. Further, nothing on this website shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. Republic Europe does not provide legal, financial or tax advice of any kind. If you have any questions with respect to legal, financial or tax matters relevant to your interactions with Republic Europe, you should consult a professional adviser.

Tax Relief (SEIS)

This business is eligible for SEIS relief - providing qualifying investors with income tax relief of 50% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Tax Relief (EIS)

This business is eligible for EIS relief - providing qualifying investors with income tax relief of 30% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Valuation (pre-money)

Valuation rounded from £7,504,708

This is the fully-diluted pre-money valuation of the business (i.e. before the new investment comes in and including issued options and other equity interests). In contrast, the post-money valuation is based on inclusion of the new investment in the value.

It is calculated as the pre-money valuation plus the amount of new investment. e.g. If Company A is ascribed a pre-money valuation of £1,200,000 by prospective investors investing £300,000, its post-money valuation is £1,500,000.

The investee business is responsible for setting its own valuation, it has not been prescribed by Seedrs.

Pitch type

Investing in a regular equity campaign is the simplest and most common way to invest in a startup. You decide which business you want to invest in, and if the campaign hits its funding target then you will become one of their shareholders. As the company becomes more valuable, so do your shares; allowing you the opportunity to share in the future success of the business.

Learn more about pitch type on Seedrs

Equity Offered

The equity offered is the percentage of the company’s shares being issued in return for the amount of investment raised.

When the amount raised is less than 100%, the equity offered is based on the target raise. Once the company has raised over 100% it is based on the total raised.

In some scenarios, entrepreneurs may accept additional direct investment after closing their Seedrs campaign. Provided this is within 6 months of the closing and on the same terms, we do not typically offer pre-emption rights on that extra investment (where you have the opportunity to invest again to maintain your percentage shareholding).

Learn more about investing and pre-emption rights.

Nominee investment

This shows if you are able to choose, when making an investment, that you be represented by, and your shareholding be managed by, the Nominee investment.

Find out more

Custodian

If you invest in this Campaign, Seedrs will act as Custodian rather than provide our standard nominee service. This is due to the fact that the business is not directly involved in the share sale and Seedrs will not benefit from any rights under a shareholder agreement. As a result, Seedrs will handle administrative tasks as we do normally, but you will not have information or voting rights, updates from the business, preemption on future fundraising, or ongoing support about business trading activity.

Learn more about Custodian here

Secondary market

This shows if the business has opted-in or opted-out of allowing its shares to be bought and sold on the secondary market.

Find out more

Direct investment

This is an option to invest and hold shares 'directly' in the company (rather than via the Nominee investment). This option is only available to those investing over the threshold amount, which is determined by the fundraising company.

If you choose to hold your shares directly, you will be responsible for any contractual or administrative arrangements with the company you are investing in.

Find out more

Payment options

We are not able to accept card payments for investments into this sector. You can pay for your investment by creating a bank transfer, using funds in your investment account or create a Pay by Bank payment. Your investment will only be completed once the funds have reached our account.

Business Involvement

This Campaign offers shares for sale in business that is not directly involved in this Campaign or the sale. As a result, the Campaign and post-investment experience, including investor rights, will differ from a business-led campaign on Seedrs. Most notably, the business will not engage with investors in the discussion forums both during and after the sale or provide any updates to investors.

Learn more here

Payment options

We are not able to accept Pay by Bank payments for investments into this sector. You can pay for your investment with a card payment, by creating a bank transfer or by using funds in your investment account. Your investment will only be completed once the funds have reached our account.

Drawdowns

This campaign offers the ability to pay for an investment by drawdowns.

Security Token

A security token is a digital asset that represents ownership or other rights. It is a digital form of traditional investments. In the future, you may be able to trade your investment through compatible exchanges.

Warning

You are following a link outside of europe.republic.com.

None of the information in constitutes part of the campaign and it has not been approved or reviewed by Seedrs.

ContinueCancel